Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | ADH1C | P00326 | 2/20 | 0.34 |
| ▸ | ADH1A | P07327 | 2/20 | 0.34 |
| ▸ | ADH4 | P08319 | 2/20 | 0.34 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.34 |
| ▸ | KDM5A | P29375 | 4/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 3/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | KDM5C | P41229 | 1/20 | 0.33 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL95388 | 0.97 | DNM1 (0.48) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL271667 | 0.97 | DNM1 (0.42) | DNM1TSHRTHRBALDH1A1CA12 | |
| SCHEMBL5469943 | 0.97 | DNM1 (0.48) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL11667597 | 0.97 | DNM1 (0.48) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL102599 | 0.97 | DNM1 (0.48) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL5479568 | 0.97 | DNM1 (0.48) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL276870 | 0.97 | DNM1 (0.48) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL276847 | 0.97 | DNM1 (0.48) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL5480820 | 0.97 | DNM1 (0.48) | DNM1TSHRTHRBCA12CA1 | |
| SCHEMBL270649 | 0.97 | DNM1 (0.48) | DNM1TSHRTHRBCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1616 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210171515-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP. | 2021-06-10 | — | — | US | claimed |
| EP-3063228-B1 | DISPERSE DYES, THEIR PREPARATION AND THEIR USE | DYSTAR COLOURS DISTRIB GMBH (DE) | 2020-04-01 | — | — | EP | claimed |
| US-20180148438-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP (US) | 2018-05-31 | — | — | US | claimed |
| US-20170266191-A1 | Therapeutic Combination of PI3K Inhibitor and a BTK Inhibitor | ACERTA PHARMA BV (NL) | 2017-09-21 | — | — | US | claimed |
| US-9745474-B2 | Acid dyes, process for the production thereof and their use | DYSTAR COLOURS DISTRIBUTION GMBH (DE) | 2017-08-29 | — | — | US | claimed |
| EP-2168968-B1 | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | OSI PHARMACEUTICALS LLC (US) | 2017-08-23 | — | — | EP | claimed |
| EP-2861670-B1 | METAL FREE REACTIVE DYES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE | DYSTAR COLOURS DISTRIB GMBH (DE) | 2017-08-16 | — | — | EP | claimed |
| US-9725597-B2 | Acid dyes, process for the production thereof and their use | DYSTAR COLOURS DISTRIBUTION GMBH (DE) | 2017-08-08 | — | — | US | claimed |
| EP-3063231-B1 | ACID DYES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE | DYSTAR COLOURS DISTRIB GMBH (DE) | 2017-05-17 | — | — | EP | claimed |
| EP-3063232-B1 | ACID DYES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE | DYSTAR COLOURS DISTRIB GMBH (DE) | 2017-05-17 | — | — | EP | claimed |
| US-20040236109-A1 | Tetrahydroquinoline derivatives | MERCK SHARP & DOHME B.V. (NL) | 2004-11-25 | — | — | US | claimed |
| JP-2002501515-A | — | — | 2002-01-15 | — | — | JP | claimed |
| US-6313344-B1 | PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-11-06 | — | — | US | claimed |
| EP-0984923-A1 | O-BENZYL OXIME ETHERS AND THEIR USE AS PESTICIDES | Novartis AG (CH) | 2000-03-15 | — | — | EP | claimed |
| EP-0527049-B1 | Quinophthalone compound | MITSUI CHEMICALS INC (JP) | 1998-12-23 | — | — | EP | claimed |
| WO-1998054125-A1 | O-BENZYL OXIME ETHERS AND THEIR USE AS PESTICIDES | NOVARTIS AG (CH) | 1998-12-03 | — | — | WO | claimed |
| EP-0416810-B1 | Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates | BEECHAM GROUP PLC (GB) | 1995-02-08 | — | — | EP | claimed |
| EP-0416810-A2 | Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates | Beecham Group p.l.c. (GB) | 1991-03-13 | — | — | EP | claimed |
| EP-0023045-B1 | IMIDAZOLECARBOXYLIC ACID DERIVATIVES OF PENICILLINS AND CEPHALOSPORINS | AJINOMOTO CO., INC. (JP) | 1984-04-11 | — | — | EP | claimed |
| EP-0052842-A2 | N,N-diaryl carbamoyl fluorides, process for preparing them and their use in the preparation of ureas, and the ureas obtained thereby | BAYER AG (DE) | 1982-06-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210171515-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | CYP7A1, CYP2E1, CYP11B1 | DNM1 3220/4885TSHR 3893/4885THRB 2447/4885 |
| US-20180148438-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | CYP7A1, CYP2E1, CYP11B1 | DNM1 3220/4885TSHR 3893/4885THRB 2447/4885 |
| US-20170266191-A1 | Therapeutic Combination of PI3K Inhibitor and a BTK Inhibitor | BTK, SYK, PIK3CD | DNM1 1944/4885TSHR 2679/4885THRB 1700/4885 |
| US-20040236109-A1 | Tetrahydroquinoline derivatives | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AOC2, HTR3C | DNM1 2276/4885TSHR 725/4885THRB 806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.